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Emerging single-cell epigenomic methods are being
developed with the exciting potential to transform
our knowledge of gene regulation. Here we review
available techniques and future possibilities, arguing
that the full potential of single-cell epigenetic studies
will be realized through parallel profiling of genomic,
transcriptional, and epigenetic information.last couple of years this has changed with numerous epi-Introduction
Epigenetics involves the study of regulatory systems that
enable heritable changes in gene expression within geno-
typically identical cells. This includes chemical modifica-
tions to DNA and the associated histone proteins, as
well as changes in DNA accessibility and chromatin con-
formation [1]. Until recently, our understanding of these
epigenetic modifications has depended entirely upon
correlations between bulk measurements in populations
of cells. These studies have classified epigenetic marks as
being associated with active or repressed transcriptional
states, but such generalizations often conceal a more
complex relationship between the epigenome and gene
expression.
Arguably, and as for many biological questions,
investigation of epigenetic regulation in general is most
usefully studied at the single-cell level, where intercellu-
lar differences can be observed leading to a more refined
understanding compared with bulk analysis [2]. Add-
itionally, the development of single-cell technologies is
key to investigating the profound remodeling of the epi-
genome during the early stages of embryonic develop-
ment, including in human samples where cell numbers* Correspondence: heather.lee@babraham.ac.uk
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be most pronounced.
High-throughput sequencing has revolutionized the
field of epigenetics with methods for genome-wide map-
ping of DNA methylation, histone modifications, chro-
matin accessibility, and chromosome conformation
(Table 1). Initially, the input requirements for these
methods meant that samples containing hundreds of
thousands or millions of cells were required; but in the
genetic features now assayable at the single-cell level
(Fig. 1). Combined single-cell methods are also emerging
that allow analyses of epigenetic–transcriptional correla-
tions thereby enabling detailed investigations of how epi-
genetic states are associated with phenotype.
In this article, we review current and emerging
methods for mapping epigenetic marks in single cells
and the challenges these methods present. We subse-
quently discuss applications of these technologies to the
study of development and disease.Single-cell methodologies and future
technological developments
Cytosine methylation and other DNA modifications
DNA methylation of cytosine (5mC) residues can be
mapped genome-wide using several methods such as
methylation-specific restriction enzymes [3], affinity
purification [4], or by using bisulfite conversion followed
by sequencing (BS-seq) [5]. The latter is considered the
gold-standard method as it allows single base resolution
and absolute quantification of DNA methylation levels.
While investigation of DNA methylation at the single-
cell level was motivated by important biological ques-
tions, until recently it was unfeasible due to the large
amount of DNA degradation caused by the bisulfite
conversion, which was traditionally performed after pre-
paring adapter-tagged libraries.distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Table 1 Survey of current and emerging single-cell epigenetics techniques
Technique Epigenomic feature Method Approach Single cell
Cytosine modification 5mC BS-seq Bisulfite converts C but not 5mC
(or 5hmC) to U so only methylated
sites are sequenced as “C”
Yes [6–8]
5mC MeDIP-seq Immunoprecipitation of 5mC DNA
followed by sequencing
Not currently possible
5mC Methyl-seq Restriction enzyme specific for 5mC
followed by sequencing
Possible
5hmC oxBS-seq 5hmC is oxidized to 5caC so that only
5mC survives bisulfite conversion.
Readout is pure 5mC and subtraction
from BS-seq determines 5hmC
Not possible for measuring
5hmC due to the need for
subtraction
5hmC TAB-seq Maps 5hmC by enzymatic oxidation
prior to bisulfite treatment: only
5hmC survives conversion
Possible
5hmC hMeDIP-seq Immunoprecipitation of 5hmC DNA
followed by sequencing
Not currently possible
5hmC Aba-seq Restriction enzyme specific for 5hmC Possible
Protein–DNA interaction Histone modification ChIP-seq Immunoprecipitation of DNA bound
to a specific histone variant or
transcription factor
Yes [17]
Transcription factor
binding
DamID Cells are transfected with a fusion of
a transcription factor gene and Dam
protein which methylates adenine
residues in proximity to the binding
site. 6 mA specific restriction digest is
used to map
Yes for nuclear lamina
interactions [18]
Chromatin structure Nucleosome positioning MNase-seq Microcococal nuclease digestion of
chromatin and sequencing of the
product which are regions protected
by nucleosomes
Possible
Nucleosome positioning NOME-seq GpC methylation of DNA not protected
by nucleosomes followed by BS-seq
Possible
DNA accessibility DNase-seq DNaseI digestion of open chromatin
into small fragments suitable for
library preparation and sequencing
Yes [23]
DNA accessibility FAIRE-seq Chromatin is crosslinked, sonicated,
and then purified by phenol–chloroform
extraction. The aqueous layer contains
only DNA not associated with protein
Not currently possible
DNA accessibility ATAC-seq Tn5 transposase enzyme fragments
and attaches adapters to open
chromatin
Yes [21, 22]
Three-dimensional
organization
Chromosome
conformation
HiC DNA is crosslinked, then restriction
digested to fragment before ligation
and reversal of the crosslinks. Resulting
fragments are hybrids from separate
genomic locations that were in close
proximity in three-dimensional space.
Paired-end sequencing is used to link
the two regions
Yes [29]
C cytosine, 5caC 5-carboxylcytosine, 5hmC hydroxymethylcytosine, 5mC methylcytosine, U uracil
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wide 5mC used a reduced representation bisulfite se-
quencing (scRBBS) approach based on enrichment of
CpG dense regions (such as CpG islands) via restriction
digestion, and it allows the measurement of approxi-
mately 10 % of CpG sites [6]. scRRBS is powerfulbecause it allows assessment of a large fraction of pro-
moters with relatively low sequencing costs, but its limi-
tation is poor coverage of many important regulatory
regions such as enhancers.
To develop true whole-genome single-cell approaches
[7, 8] technological developments have been based on a
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scDNA-seq
Droplet
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Immuno-
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Fig. 1 Epigenomics and the spectrum of single-cell sequencing technologies. The diagram outlines the single-cell sequencing technologies
currently available. A single cell is first isolated by means of droplet encapsulation, manual manipulation, fluorescence-activated cell sorting (FACS)
or microfluidic processing. The first examples of single-cell multi-omic technologies have used parallel amplification or physical separation to
measure gene expression (scRNA-seq) and DNA sequence (scDNA-seq) from the same cell. Note that single-cell bisulfite conversion followed by
sequencing (scBS-seq) is not compatible with parallel amplification of RNA and DNA, as DNA methylation is not conserved during in vitro
amplification. Single-cell epigenomics approaches utilize chemical treatment of DNA (bisulfite conversion), immunoprecipitation or enzymatic digest
(e.g., by DNaseI) to study DNA modifications (scBS-seq and scRRBS), histone modifications (scChIP-seq), DNA accessibility (scATAC-seq, scDNase-seq),
chromatin conformation (scDamID, scHiC)
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bisulfite conversion is performed before library prepar-
ation so that DNA degradation does not destroy
adaptor-tagged fragments [9]. As a result, methylation in
up to 50 % of the CpG sites in a single cell can now be
measured and this has allowed, for example, thedetection of high variability between single cells in distal
enhancer methylation (not usually captured by scRRBS)
in mouse embryonic stem cells (ESCs) [7].
Building on this method has allowed BS-seq and
RNA-seq in parallel from the same single cell
(scM&T-seq) [10]. This was made possible by way of
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from DNA (genome and transcriptome sequencing or
G&T-seq [11]), and this now allows intricate investi-
gations of links between epigenetic and transcriptional
heterogeneity within a particular cell and tissue type.
Hydroxymethylated cytosine (5hmC) is also thought to
have a role in epigenetic gene regulation and has been
analyzed in bulk samples using modified bisulfite se-
quencing methods [12, 13], 5hmC-specific restriction
enzymes [14], or immunoprecipitation [15]. Of the
currently established methods, TET-assisted bisulfite se-
quencing (TAB-seq) [12] and Aba-seq [14] could poten-
tially be adapted to single cells. In TAB-seq, 5hmC is
first enzymatically glucosylated in order to prevent its
recognition by TET1, which is then used to oxidize 5mC
to 5-formylcytosine and 5-carboxylcytosine which, along
with unmodified cytosines, are sensitive to bisulfite con-
version. These initial enzymatic steps could be performed
in a single-tube reaction immediately before processing by
single-cell BS-seq (scBS-seq). In Aba-seq, 5hmc is gluco-
sylated prior to digestion with AbaSI, an enzyme that
recognizes 5-glucosylhydroxymethylcytosine, and then
prepared for sequencing by adapter ligation. Importantly,
both of these techniques would be compatible with DNA
purified using G&T-seq [11] thus allowing parallel mea-
surements of 5hmC and poly-A RNA within the same
single cell.
Histone modifications and transcription factor binding
Histones can carry a diversity of covalent modifications
that are associated with different genomic features and
transcriptional states [16]. Mapping of histone marks is
typically carried out using chromatin immunoprecipita-
tion followed by sequencing (ChIP-seq). Performing
ChIP-seq at the single-cell level is extremely challenging
due to background noise caused by nonspecific antibody
pull-down, which increases as the level of target antigen
decreases. This was overcome recently by performing
the immunoprecipitation step on chromatin from a pool
of single cells that had already undergone micrococcal
nuclease (MNase) digestion and barcoding, so that the
pull-down is effectively performed on thousands of cells.
This approach used a droplet-based microfluidics setup
to process large numbers of cells in parallel [17], and be-
cause only a limited number of valid sequencing reads
are obtained per single cell a large number of cells has
to be sequenced in order to evaluate intercellular
variability.
Protein–DNA interactions in single cells have been
mapped using DamID, in which a cell line expresses low
levels of a fusion protein of Escherichia coli deoxyadeno-
sine methylase (Dam) and the protein under study. Dam
methylates DNA on adenine residues adjacent to sites of
protein binding. Methylated sites are then cut by themethylation-sensitive restriction enzyme DpnI, followed
by ligation of sequencing adapters. This technique has
been successfully employed to study interactions with
the nuclear lamina in single cells [18]. Currently reso-
lution is in the order of 100 kb, which to some extent
limits its applications, but future optimizations could see
improvements such that it could be used for mapping
transcription factor binding sites in single cells. In
addition, single-cell DamID could also support genome-
wide analysis of histone modifications by using Dam fu-
sion with specific histone readers or modifiers.
Chromatin structure and chromosome organization
A raft of publications was seen in 2015 describing
methods for mapping open chromatin in single cells.
The first of these was based on the assay for
transposase-accessible chromatin (ATAC-seq) which
uses a Tn5 transposase enzyme to simultaneously
fragment DNA and attach adapter sequences in a
process called tagmentation [19]. Open chromatin re-
gions can be defined by introducing the transposase
into intact nuclei, where it acts on only DNA free of
nucleosomes and transcription factors [20]. ATAC-seq
was first adapted to single-cell resolution by employ-
ing a “combinatorial indexing” strategy in which the
tagmentation is carried out on 96 pools of a few
thousand nuclei, introducing a unique barcode to
each pool. The 96 reactions are then pooled and split
before a second barcode is introduced by polymerase
chain reaction (PCR). The number of pools and cells
per pool are optimized so that the probability that a
particular barcode combination originates only from a
single cell is kept sufficiently high [21]. In parallel a
second single-cell ATAC-seq method has been de-
scribed, which makes use of a commercially available
microfluidics device to carry out the transposition re-
action on individual cells [22]. This approach has re-
sulted in a large increase in resolution compared with
the combinatorial indexing method, mapping an aver-
age of 70,000 reads per cell compared with 3000, al-
though throughput was substantially lower. Finally,
investigation of open chromatin genomic regions has
been achieved in single cells by employing a DNase-
seq approach to map regions that are DNaseI hyper-
sensitive. scDNase-seq provides an improved reso-
lution of 300,000 mapped reads per single cell, albeit
with a very low mapping efficiency (2 %) and even
lower throughput [23]. Both of these methods could
be combined with RNA-seq, either by way of physical
separation [10] or parallel amplification [24].
In bulk samples, genome-wide nucleosome occu-
pancy has been assayed by sequencing the products
of MNase digestion [25] and by nucleosome occu-
pancy and methylome sequencing (NOMe-seq) [26].
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methylate exposed GpC dinucleotides while DNA bound
by nucleosomes is protected. Sequencing of the bisulfite-
converted DNA can then be used to map nucleosome po-
sitions and this is particularly attractive for single-cell use
since it will also give a readout of CpG methylation within
the same single cell. Indeed nucleosome positioning has
already been studied using locus-specific bisulfite PCR in
the yeast PHO5 gene, which revealed significant variability
between cells that correlated with gene expression [27].
Single-cell nuclei prepared according to this method
should be compatible with scBS-seq.
In addition to defining the linear chromatin
organization of single cells, it is now possible to as-
sess chromosome conformation at the single-cell
level using a HiC-based method [28, 29]. Single-cell
HiC is currently limited in its resolution but still
allows description of the individual chromosome
organization and compartmentalization, as well as in-
terchromosomal interactions. This is a good example of
how single-cell approaches can really provide cutting-edge
tools, as regular HiC was traditionally performed on mil-
lions of cells resulting in an average of all chromosome
organization within the cell population and hence some
ambiguity in interpretation of the results.
Advances in equipment to perform single-cells methods
Development of single-cell approaches is intimately
linked to the development of physical equipment and
devices. The first step in any single-cell analysis is the
isolation and lysis of single cells from culture or dissoci-
ated tissue. This can be performed manually with a pip-
ette and a microscope but such methods cannot
realistically be scaled up for higher-throughput require-
ments. Fluorescence-activated cell sorting (FACS) can be
used to isolate many thousands of single cells into mi-
crotiter plates in a short time with the additional benefit
of being able to select cells based on a subset of fluores-
cent markers. Microfluidics systems have been devel-
oped, such as the C1 from Fluidigm, in which cells are
trapped in chambers in which lysis and RNA-seq library
preparation can subsequently be carried out. One advan-
tage of this system is that captured cells are photo-
graphed in the system meaning that morphology of cells
and presence of doublets can be assessed post hoc; how-
ever, these devices are currently only low-to-medium
throughput, typically processing only 96 cells at one
time. Recently, an innovative approach to generating
single-cell libraries using microfluidics has emerged,
which allows a significant increase in library preparation
throughput compared with other methods. Cells are
encapsulated within aqueous droplets in flowing oil, in
which early stages of library preparation including cell-
specific barcoding are performed, before being pooledfor downstream reactions. In this way, thousands of cells
are processed in parallel, with vastly reduced costs per
cell and improved sensitivities compared with conven-
tional tube-based methods. So far this approach has
been applied to RNA-seq [30–32] and ChIP-seq [17] but
in principle it could also be adapted to other methods
such as BS-seq. Commercialization of droplet-sequencing
technologies has already begun, meaning that these
single-cell methodologies will be easily accessible and will
be able to achieve their full potential.
In parallel we are witnessing a significant improvement
in the field of single-molecule sequencing technologies
with the potential to measure DNA modifications dir-
ectly from native DNA and over tens of kilobases on the
same molecule. This is particularly relevant since PCR
amplification, bisulfite treatment, and other manipula-
tions involved in library preparation can introduce tech-
nical artifacts, e.g., CG bias in BS-seq libraries. There are
currently two single-molecule sequencing technologies
on the market. The first of these, single-molecule
real-time sequencing [33] as employed by the Pacific
Biosciences RSII and Sequel machines works by real-
time measurements of incorporating nucleotides and
has been shown to discriminate cytosine from 5mC
and 5hmC, although much effort is yet required to
enable this analysis to be performed in a flexible way
and routinely due to the subtle and context-specific
effects of DNA modifications on incorporation kinet-
ics [34]. The other technology, marketed by Oxford
Nanopore, uses measurements of electrostatic charge
as a DNA strand passes through a protein nanopore.
While this technology is still in its infancy, in
principle modified bases such as 5mC and derivatives
could be detected [35]. These technologies currently
require microgram quantities of DNA and therefore
are not directly applicable to single cells; however, the
use of cell-specific barcoding followed by pooling
many thousands of single cells could allow analysis of
individual cells.
Quality control of single-cell epigenomic libraries
Quality control of sequencing data is crucial in order to
avoid technical artifacts. This is especially true of single-
cell sequencing, which is technically noisy due to low
amounts of starting material, often resulting in variable
capture efficiencies. The large number of amplification
cycles that are needed often means that reagent contam-
ination or sample cross-contamination is a very real
problem and so sequencing of negative controls is rec-
ommended. Mapping efficiency or coverage cut-offs are
also useful in order to eliminate cells that have
performed much worse than the average. The use of
spike-in controls may also be useful for some methods, for
example to measure underconversion and overconversion
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of cell dissociation on downstream analysis, since harsh en-
zymatic digestion of solid tissues is thought to influence
single-cell transcriptomic studies [36]. Although epige-
nomic profiles are generally thought to be more stable than
transcriptomes, the dissociation of cells should be
performed as quickly and as mildly as possible to
minimize the potential influence on single-cell librar-
ies. Finally, batch effects can have a profound influ-
ence on single-cell datasets [37], so it is important to
process samples in parallel wherever possible.
Computational challenges to analyzing single-cell
epigenomic data
The main computational challenges in single-cell data
arise from the technical variability in the methods; this
is due to low and variable capture efficiencies and biases
introduced during PCR. This is a problem since it can
be difficult to determine whether an observed difference
is due to biological or technical reasons. These have
been discussed in detail with respect to single-cell RNA-
seq [38] where technical variability can be measured and
normalized by use of synthetic spike-ins and unique
molecular identifiers that are introduced during re-
verse transcription [39]. Single-cell epigenomic methods
would likely benefit from similar strategies. Additionally,
local correlations in epigenetic marks and correlations be-
tween epigenetic features and the underlying genetic se-
quence mean that missing information can be imputed in
order to reduce the effect of low coverage. Such methods
are in development and will be much improved
when combined single-cell technologies become more
sophisticated.
Future applications of single-cell epigenomics
Single-cell approaches to refine our understanding of
epigenetic regulation
As mentioned above, epigenetic modifications have been
characterized as transcriptionally repressive or activating
based on correlations made in bulk cell populations.
However, growing evidence has exposed the naivety of
this assumption and revealed the great complexity of
epigenetic regulation. For example, 5mC has long been
considered to be a transcriptionally repressive mark
since promoter methylation is negatively correlated with
gene expression. However, in some cases DNA methyla-
tion of gene bodies has been positively correlated with
transcription, demonstrating that the genomic context
can influence the biological outcome [40]. Furthermore,
global DNA hypomethylation seen in naive ESCs is not
associated with widespread transcriptional activation
[41, 42], demonstrating that the strength of regulatory
links between DNA methylation and transcription can
also vary depending on the developmental stage andcellular context. Since the discovery of 5hmC and other
oxidized derivatives of 5mC, the situation has become
even less clear, with inconsistent reports on the bio-
logical functions of these modifications [43–46].
Therefore, the use of single-cell approaches has the
potential to refine our understanding of DNA modifi-
cations as regulatory epigenetic marks. The recent
development of combined single-cell methods (e.g.,
scM&T-seq) will be invaluable to such studies [10]. In
addition, the very low levels of 5hmC measured in
bulk cell samples (e.g., less than 5 % of CpG sites in
primed ESCs) indicate that only a few cells in that
population have this modification at any particular
cytosine residue. Therefore, parallel profiling of 5hmC
and transcription will impact profoundly on our un-
derstanding of this epigenetic mark. In the future, it
may even be possible to assay multiple epigenetic
features (e.g., DNA methylation and chromatin acces-
sibility) together with gene expression in the same
single cell, leading to further refinements in our view
of the epigenomic influence on the transcriptome.
According to the classical definition, epigenetic modi-
fications must be heritable through cell divisions. While
the mechanisms governing 5mC maintenance during
DNA replication have been well described [47], the in-
heritance of other components of the epigenome is
understood poorly. For example, the means by which
histone modifications are conserved through DNA
replication remain unclear [48]. This represents another
application of single-cell approaches, in which one can
imagine in vitro systems where mother and daughter
cells can be sequenced to reveal the distribution of
epigenetic marks between these two cells. When
coupled with manipulations of epigenetic modulators
(e.g., knockout models of histone-modifying enzymes),
such an approach would allow the true nature of epi-
genetic propagation to be elucidated.
Single-cell approaches to understand developmental
processes and improve regenerative medicine
Single-cell transcriptional profiling has revealed population
substructure in various developmental contexts [31, 32,
49–52]. In combination with lineage-tracing experiments,
this information can be used to decipher the cellular
hierarchy underlying complex tissues, giving unprecedented
information on the molecular mechanisms governing dif-
ferentiation processes. Epigenetic mechanisms are conven-
tionally thought to restrict cell-fate decisions during
development [53], so single-cell epigenomics studies will
add valuable detail to these tissue hierarchies. It is also not
excluded that in certain situations epigenetic information
could be instructive for cell-fate decisions, and finely timed
combined single-cell profiling techniques may provide in-
sights into this important question.
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the mammalian epigenome [38–40], including incorpor-
ation of maternal histones into the paternal genome fol-
lowing fertilization, and mechanisms leading to global
DNA demethylation in both the preimplantation embryo
and developing primordial germ cells. For this reason,
many single-cell epigenomics techniques have been
applied to embryonic development, taking mouse ESCs
as a model system [6–8, 10, 29]. These studies have
revealed intercellular epigenetic heterogeneity in cells
poised for differentiation, which may have biological im-
portance in lineage priming [54].
The near future will undoubtedly witness the applica-
tion of single-cell epigenomic approaches in vivo. For
example, mouse zygotes fertilized in vitro and embryos
resulting from natural matings will be studied to under-
stand epigenome dynamics during this critical stage of
development. Due to the low cell numbers associated
with these samples, FACS isolation of single cells is in-
feasible, so single cells will be manually picked after em-
bryo dissociation. For the early stages of development, it
should be possible to study every cell isolated from an
embryo, while at later time points (E6.5 onwards) the in-
creasing cell number may necessitate focused studies on
specific cell lineages or on representative subpopulations
of each lineage. A limitation to these studies will be the
loss of spatial information upon embryo dissociation.
Complementary studies including in vivo imaging of
lineage-specific genes will be used to map cell types
identified by single-cell sequencing back to the three-
dimensional embryo [55]. By employing single-cell
multi-omics, these studies will reveal the fundamental
processes of cell-fate specification and establish an atlas
of differentiation in which every tissue type can be
traced back to its embryonic origins. This information
will bring light to one of the most fascinating processes
of biology, clarifying key questions such as whether cell-
type-specific epigenetic marks are established during
lineage priming prior to cell-fate commitment.
In addition, these experiments will have important
applications in the clinic. For example, such informa-
tion will assist efforts to reprogram cells from adult
tissues into induced pluripotent stem cells (iPSCs).
The inefficiency of this process is currently limiting
the applicability of iPSCs to regenerative medicine, so
single-cell gene expression analyses have been
performed to decipher the molecular pathway to suc-
cessful reprogramming [56–58]. Somatic cell repro-
gramming is known to be associated with dramatic
nuclear remodeling [59, 60], so single-cell epigenomic
studies will add an important layer of information.
Furthermore, a detailed understanding of the mecha-
nisms involved in cell-fate decisions in vivo will
improve our ability to generate specific cell types(from iPSCs or other stem cells) for therapeutic use in
regenerative medicine.
Single-cell approaches to assess the complexity of cancer
Cancer is a highly heterogeneous disease with molecular
characteristics that depend on the tissue of origin and
differ between patients. Intratumor heterogeneity (within
patients) is not fully understood, but includes regional
differences that reflect tumor microenvironment, differ-
ences between primary and metastatic disease, and gen-
etic diversity resulting from tumor evolution. Emerging
single-cell sequencing technologies will reveal the full
extent of intratumor heterogeneity and this will have
many applications for clinical management as different
cell types are likely to play distinct roles in disease initi-
ation, metastasis, and drug resistance [61]. Already,
single-cell DNA sequencing has found evidence of clonal
evolution in multiple cancer types, and has identified
founder mutations and subclonal mutations that have
implications for cancer progression [62, 63]. Likewise,
single-cell transcriptome profiling has been used to iden-
tify cell subpopulations within cancers, including cells
with transcriptional programs suggesting stem cell activ-
ity [64–66]. These studies have extended our under-
standing of disease progression and have improved our
ability to predict disease outcome.
The epigenome is known to be drastically remodeled
in multiple malignancies, and therapeutics targeting
DNA methyltransferases and histone deacetylases are
used in several cancer types [67]. Typically, loss of DNA
methylation is observed on a global scale while gains in
DNA methylation occur in a more specific manner, and
these changes are accompanied by abnormal nucleosome
positioning and chromatin modifications. Descriptions
of intertumor epigenetic heterogeneity have yielded clin-
ically relevant information (e.g., stratification of triple-
negative breast cancers into subgroups with differing
prognosis [68]), but the full extent of epigenetic intratu-
mor heterogeneity remains unknown and will rely upon
single-cell analyses.
In the future, single-cell epigenomic studies will com-
plement single-cell transcriptome and genome analysis
in defining rare subpopulations of cells with clinically
significant characteristics. For example, cancer stem cells
could be characterized using these single-cell studies,
such that targeted therapeutics can be designed to pre-
vent disease recurrence following conventional therapy
[69]. Single-cell epigenomic studies may also lead to the
development of novel screening strategies based on cir-
culating tumor cells and cell-free DNA, where patient
material is severely limited. In particular, DNA methyla-
tion is an attractive target for cancer screening as it pro-
vides cell-type-specific information that is more stable
than transcriptional profiles.
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Fig. 2 Future applications of single-cell epigenomics. The full potential of emerging single-cell epigenomic techniques will be realized through
integration with transcriptome and genome sequencing. Single-cell multi-omics will be applied to biological questions involving the molecular
mechanisms of epigenetic regulation (e.g., the functional consequences of rare DNA modifications), intercellular heterogeneity, and rare cell types
(e.g., in early development). scATAC-seq single cell assay for transposase-accessible chromatin, scBS-seq single-cell bisulfite sequencing, scChIP-seq
single-cell chromatin immunoprecipitation followed by sequencing, scDNase-seq single-cell DNase sequencing, scHiC single-cell HiC, scRRBS
single-cell reduced representation bisulfite sequencing
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In conclusion, the field of single-cell epigenomics is in
its infancy but with the rapid pace of technological de-
velopment and the increasingly recognized importance
of intercellular heterogeneity we anticipate enormous
progress over the next few years. Methods are evolving
such that researchers will soon be able to profile mul-
tiple epigenetic marks within the same single cell and do
so in combination with transcriptional and genetic infor-
mation (Fig. 2). Correlations between features at precise
genomic locations will lead to a more refined appreci-
ation of how epigenetic processes interact with one
another to control gene expression. Ultimately this has
the potential to transform our understanding of how the
phenotype of the cell is maintained and how it is
perturbed in disease—a subject that is fundamental
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